← Ticker index
JNJ
Ticker
JNJ
Johnson & Johnson
Healthcare
Congressional Trades
269
by 34 members
Ticker disclosure brief
Congressional disclosure records for JNJ
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Lloyd Doggett
BUY · 2026-06-09
Largest range
$100K – $250K
George Whitesides
Longest observed gap
330d
C. Franklin
Highest 30d vs SPY
54.0%
Ro Khanna
Purchase rows
141
52%
Sale rows
121
45%
Disclosed midpoint
$5.2M
range estimate
Unique Traders
34
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats128 · 48%
Republicans72 · 27%
Federal awards
all →- 2026-06-30$100KDepartment of Veterans AffairsENERGY SYSTEM
- 2026-04-16$134KDepartment of Veterans AffairsPURCHASE 2 NGEN CARTO3 MAPPING SYSTEMS FOR TVHS NASHVILLE
- 2026-04-16$25KDepartment of Veterans AffairsLAPAROSCOPIC
- 2026-04-01$57KDepartment of Veterans AffairsMANDIBLE IMPLANT
- 2026-02-25$35KDepartment of Health and Human ServicesJOHNSON & JOHNSON HEALTH CARE SYSTEMS INC:1106694 [26-002571]
- 2026-01-27$45KDepartment of Veterans AffairsSURGICAL SUPPLIES AND DISPOSABLE ITEMS USED DURING A PATIENT'S SURGERY AT THE MARTINSBURG VA MEDICAL CENTER.
Lobbying filings
all →- 2026-07-10$60KJOHNSON & JOHNSON SERVICES INCIssues related to appropriations, animal welfare, and health policy. Issues related to appropriations, animal welfare, and health policy.
- 2026-07-10$30KJOHNSON & JOHNSONHR 6549, VA Contracting and Procurement Act PBM Medical Supply Chain program reforms, MSPV, PSAS, IT HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act
- 2026-07-05$0BROWNSTEIN HYATT FARBER SCHRECK LLP OBO JOHNSON & JOHNSON
- 2026-04-20$3.5MJOHNSON & JOHNSON SERVICES INC- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Acc
- 2026-04-20$100KJOHNSON & JOHNSON SERVICES INC.Pharmacy Benefit Managers. 340B. Tort Litigation reform. Health care supply chain. S.864: HELP Copays Act. Inflation Reduction Act Implementation.
- 2026-04-20$80KJOHNSON & JOHNSON SERVICES INC.Issues related to mental health. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety. Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. Issues related to Most Favored Nation drug pricing. Monitor implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Issues related to litigation reform. Issues related to tariffs.
- 2026-04-20$60KJOHNSON & JOHNSON SERVICES INC.Issues related to public health, science and technology, sustainability, innovation, and competition. Issues related to public health, science and technology, sustainability, innovation, and competition.
- 2026-04-20$60KJOHNSON & JOHNSON SERVICES INCGeneral issues regarding health care and public health issues. Issues related to drug pricing, including the 340b program. Issues related to maternal health, patient access and treatment, health care science and technology. Issues related to One Big Beautiful Bill Act (H.R.1) implementation. Issues related to the FY26 and FY27 budget and appropriations process. H.R.2675 - Protecting Our Courts from Foreign Manipulation Act of 2025 H.R.1109 - Litigation Transparency Act of 2025 General issues related to third party litigation.
- 2026-04-20$50KJOHNSON & JOHNSON SERVICES INCIssues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation. Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney advertising. Vaccine coverage issues. Maternal health legislation.
- 2026-04-20$50KJOHNSON & JOHNSON SERVICES INC.Issues related to cardiovascular health; H.R.5343 / S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025; issues related to Heart Recovery Awareness Day and H. Res. 1301, designating February 20th Heart Recovery Awareness Day
Loading trade analytics…
All Disclosed Trades
Page 6 · 25 of 269 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-04-09 | DJosh Gottheimer | SELL | $1K – $15K | 35d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 22d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 21d | receipt → |
| 2025-04-04 | DRo Khanna | BUY | $1K – $15K | 38d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 21d | receipt → |
| 2025-04-23 | DRo Khanna | BUY | $1K – $15K | 19d | receipt → |
| 2025-04-04 | DRo Khanna | BUY | $1K – $15K | 38d | receipt → |
| 2025-04-29 | DGilbert Cisneros | SELL | $1K – $15K | 8d | receipt → |
| 2025-04-29 | DGilbert Cisneros | SELL | $1K – $15K | 7d | receipt → |
| 2025-04-29 | DGilbert Cisneros | SELL | $1K – $15K | 7d | receipt → |
| 2025-04-08 | RRobert Bresnahan | SELL | $1K – $15K | 20d | receipt → |
| 2025-03-24 | DGeorge Whitesides | SELL | $100K – $250K | 30d | receipt → |
| 2025-03-24 | DGeorge Whitesides | SELL | $100K – $250K | 30d | receipt → |
| 2025-03-03 | RBruce Westerman | BUY | $1K – $15K | 44d | receipt → |
| 2025-03-03 | RBruce Westerman | BUY | $1K – $15K | 44d | receipt → |
| 2025-03-05 | RJefferson Shreve | BUY | $15K – $50K | 37d | receipt → |
| 2025-03-05 | RJefferson Shreve | BUY | $15K – $50K | 37d | receipt → |
| 2025-03-07 | DJosh Gottheimer | SELL | $1K – $15K | 34d | receipt → |
| 2025-03-07 | DJosh Gottheimer | SELL | $1K – $15K | 34d | receipt → |
| 2025-03-04 | DLloyd Doggett | BUY | $1K – $15K | 34d | receipt → |
| 2025-03-04 | DLloyd Doggett | BUY | $1K – $15K | 34d | receipt → |
| 2025-03-31 | DGilbert Cisneros | BUY | $15K – $50K | 7d | receipt → |
| 2025-03-31 | DGilbert Cisneros | BUY | $15K – $50K | 7d | receipt → |
| 2025-03-04 | DLloyd Doggett | BUY | $1K – $15K | 31d | receipt → |
| 2025-03-24 | DGeorge Whitesides | SELL | $100K – $250K | 0d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.